1 / 10

Reasons patients were excluded from the switch from atorvastatin to simvastatin

Reasons patients were excluded from the switch from atorvastatin to simvastatin. J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23. Outcome of patients originally being prescribed 10 or 20 mg atorvastatin. J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23.

lenci
Télécharger la présentation

Reasons patients were excluded from the switch from atorvastatin to simvastatin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Reasons patients were excluded from the switch from atorvastatin to simvastatin J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  2. Outcome of patients originally being prescribed 10 or 20 mg atorvastatin J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  3. Total serum cholesterol before and after switching from atorvastatin to simvastatin J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  4. Total cholesterol before (closed diamonds) and after (open squares) switching from atorvastatin to simvastatin - Dotted line marks audit standard J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  5. Reasons patients were excluded from the switch from losartan to candesartan J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  6. Reasons patients were switched back to losartan J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  7. Outcome of patients originally being prescribed losartan J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  8. Blood pressure before and after switching from losartan to candesartan J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  9. Systolic and diastolic blood pressure recordings before (closed diamonds) and after (open squares) switching from losartan to candesartan for patients without diabetes or cardiovascular disease (CVD; A), with diabetes (B) and with CVD (C). Dotted lines indicated audit standard J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

  10. Outcome Representative sample of respondents’ comments on how they felt when they were asked to change their medication J. A. Usher-Smith, et al. Int J Clin Pract 2007; 61:15–23

More Related